documents: FDA-2024-N-5331-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2024-N-5331-0001 | FDA | FDA-2024-N-5331 | Joint Meeting of the Drug Safety and Risk Management Advisory Committee and the Anesthetic and Analgesic Drug Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments— Extended-Release/Long-Acting Opioid Analgesic Postmarketing Requirement | Notice | Request for Comments | 2024-12-09T05:00:00Z | 2024 | 12 | 2024-12-09T05:00:00Z | 2025-02-05T04:59:59Z | 2025-04-21T15:10:18Z | 2024-28811 | 0 | 0 | 0900006486856209 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref